Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 7, 2007, Pages 1393-1396

  Grenyer, Brin F S ^a   Crowe, Trevor ^a   Meyer, Barbara ^a   Owen, Alice J ^a   Grigonis Deane, Elizabeth M ^a   Caputi, Peter ^a   Howe, Peter R C ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Major depression; Omega 3

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FECES; FEMALE; FLATULENCE; HEARTBURN; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT CARE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMACH PAIN; SUPPLEMENTATION; TASTE DISORDER; TUNA; VITAMIN BLOOD LEVEL;

EID: 84950170767     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.004     Document Type: Article

References (22)

1. Anderson G.J., Connor W.E., and Corliss J.D. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatr Res 27 (1990) 89-97
2. Diguer L., Barber J., and Luborsky L. Three concomitants: personality disorders, psychiatric severity, and outcome of dynamic psychotherapy of major depression. Am J Psychiatry 150 (1993) 1246-1248
3. Elkin I., Shea T., Watkins J.T., Imber S.D., S S.M., Collins J.F., et al. National Institute of Mental Health Treatment of Depression Collaborative Research Programme: general effectiveness of treatments. Arch Gen Psychiatry 46 (1989) 971-982
4. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) (1997), American Psychiatric Press, Washington DC
5. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (1997), American Psychiatric Press, Washington DC
6. Frangou S., Lewis M., and McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188 (2006) 46-50
7. Gueorguieva R., and Krystal J.H. Move over ANOVA: progress in analysing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 61 (2004) 310-317
8. Hibbeln J.R. Fish consumption and major depression. The Lancet 351 (1998) 1213
9. Lepage G., and Roy G.C. Direct esterification of all classes of lipid in a one step reaction. J Lipid Res 27 (1986) 114-120
10. Marangell L.B., Martinez J.M., Zboyan H.A., Kertz B., Kim H.F.S., and Puryear L.J. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160 (2003) 996-998
11. Murck H., Song C., Horrobin D.F., and Uhr M. Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression. Int J Neuropsychopharmacol 7 (2004) 341-349
12. Nemets B., Stahl Z., and Belmaker R.H. Addition of omega-e fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159 (2002) 477-479
13. Nemets H., Nemets B., Apter A., Bracha Z., and Belmaker R.H. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163 (2006) 1098-1100
14. Owen A.J., Batterham M.J., Probst Y., Grenyer B.F.S., and Tapsell L.C. Low plasma vitamin E levels in depression: diet or disease?. Eur J Clin Nutr 59 (2005) 304-306
15. Peet M., and Horrobin D.F. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59 (2002) 913-919
16. Puri B.K., Counsell S.J., Richardson A.J., and Horrobin D.F. Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry 59 (2002) 91-92
17. Silvers K.M., Woolley C.C., Hamilton F.C., Watts P.M., and Watson R.A. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fat Acids 72 (2005) 211-218
18. Siscovick D.S., Raghunathan T.E., King I., Weiunmann S., Bovbjerg V.E., Kushi L., et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 71 (2000) 208-212
19. Stoll A.L., Marangell L., and Severus W.E. The effects of olive oil on w3 fatty acids and mood disorders: in reply. Arch Gen Psychiatry 57 (2000) 715
20. Stout R.L., Wirtz P.W., Carbonari J.P., and Del Boca F.K. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol S12 (1994) 70-75
21. Su K.-P., Huang S.-Y., Chiu C.-C., and Shen W.W. Omega-3 acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13 (2003) 267-271
22. Tanskanen A., Hibbeln J.R., Hintikka J., Haatainen K., Honkalampi K., and Viinamaki H. Fish consumption, depression and suicidality in a general population. Arch Gen Psychiatry 58 (2001) 512-513